EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease

Jong Bin Choi, Dong-Won Seol, Hyo-Sang Do, Hee-Young Yang, Taek-Min Kim, Youkyeong Gloria Byun, Jae-Min Park, Jinhyuk Choi, Seon Pyo Hong, Won-Suk Chung, Jae Myoung Suh, Gou Young Koh und 3 weitere

Molecular Therapy · 2023

DOI: 10.1016/j.ymthe.2023.02.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2023. Verfasst von Jong Bin Choi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, KAIST, Daejeon 34141, Republic of Korea. Hauptthemen laut MEDLINE: Fabry Disease. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fabry disease (FD), a lysosomal storage disorder, is caused by defective α-galactosidase (GLA) activity, which results in the accumulation of globotriaosylceramide (Gb3) in endothelial cells and leads to life-threatening complications such as left ventricular hypertrophy (LVH), renal failure, and stroke. Enzyme replacement therapy (ERT) results in Gb3 clearance; however, because of a short half-life in the body and the high immunogenicity of FD patients, ERT has a limited therapeutic effect, particularly in patients with late-onset disease or progressive complications. Because vascular endothelial cells (VECs) derived from FD-induced pluripotent stem cells display increased thrombospondin-1 (TSP1) expression and enhanced SMAD2 signaling, we screened for chemical compounds that could downregulate TSP1 and SMAD2 signaling. Fasudil reduced the levels of p-SMAD2 and TSP1 in FD-VECs and increased the expression of angiogenic factors. Furthermore, fasudil downregulated the endothelial-to-mesenchymal transition (EndMT) and mitochondrial function of FD-VECs. Oral administration of fasudil to FD mice alleviated several FD phenotypes, including LVH, renal fibrosis, anhidrosis, and heat insensitivity. Our findings demonstrate that fasudil is a novel candidate for FD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry DiseaseAnimalsMiceEndothelial Cellsalpha-GalactosidasePhenotypeEnzyme Replacement Therapy1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine

Stichwörter der Autor:innen

Fabry diseasedrug screeningfasudiliPSCsvascular endothelial cells

Substanzen

alpha-Galactosidasefasudil1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine

Autor:innen und Institutionen

  • Department of Biological Sciences, KAIST, Daejeon 34141, Republic of Korea.
  • Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu 41061, Republic of Korea.
  • Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
  • Graduate School of Medical Science and Engineering, KAIST, Daejeon 34141, Republic of Korea.
  • Department of Biological Sciences, KAIST, Daejeon 34141, Republic of Korea; Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF), Daegu 41061, Republic of Korea.
  • Center for Vascular Research, Institute for Basic Science (IBS), Daejeon 34141, Republic of Korea.

Zitieren

APA

Choi, J. B., Seol, D. W., Do, H. S., Yang, H. Y., Kim, T. M., Byun, Y. G., Park, J. M., Choi, J., Hong, S. P., Chung, W. S., Suh, J. M., Koh, G. Y., Lee, B. H., Wee, G., & Han, Y. M. (2023). Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2023.02.003

Vancouver

Choi JB, Seol DW, Do HS, Yang HY, Kim TM, Byun YG, et al. Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease. Molecular Therapy. 2023. doi:10.1016/j.ymthe.2023.02.003

BibTeX
@article{Choi2023,
  author = {Choi, Jong Bin and Seol, Dong-Won and Do, Hyo-Sang and Yang, Hee-Young and Kim, Taek-Min and Byun, Youkyeong Gloria and Park, Jae-Min and Choi, Jinhyuk and Hong, Seon Pyo and Chung, Won-Suk and Suh, Jae Myoung and Koh, Gou Young and Lee, Beom Hee and Wee, Gabbine and Han, Yong-Mahn},
  title = {Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease},
  journal = {Molecular Therapy},
  year = {2023},
  doi = {10.1016/j.ymthe.2023.02.003}
}
Kostenlos starten →